ESMO 2023: Clinical Considerations & Payer Perspectives
Late October saw the annual gathering of oncologists and industry in Madrid for ESMO 2023, bringing with it a wave of new clinical results across cancers and a...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Mr. Aaron Everitt is a principal in the Life Sciences Practice of CRA. He has over five years of consulting experience in Pricing & Market Access, across the EU and US, with experience in LATAM, APAC and MEA. Dr. Everitt has a PhD background in immunology and virology.